Supply Chain Disruptions Limits Growth in the Sleep Diagnostics Market

Obstructive sleep apnea (OSA) affects roughly one out of every five people in the United States and it is estimated that 85% of people suffering from OSA are underdiagnosed (Santilli, et al., 2021).

Topics: Diagnostics Pharmaceuticals Medical Devices Industry Insights

U.S. Medical Spas Industry Boosted by Pandemic, with Strong Growth Outlook to 2027

The U.S. medical spas industry has more than tripled in size (in terms of revenue) since 2012, and was worth $17.5 billion in 2022. The COVID-19 pandemic actually boosted this business, as consumers in Zoom meetings viewed their facial faults and decided to correct them.

Topics: Travel & Leisure Pharmaceuticals Industry Insights

Global Breast Reconstruction Market Growth: Analysis and Forecasts

The survival rate of breast cancer has improved significantly over the last decade, shifting the focus of treatment towards quality of life, as opposed to simply survival. Breast cancer treatment typically consists of surgery, radiation therapy and/or medicines. A common procedure many breast cancer patients undergo is a mastectomy.

Topics: Pharmaceuticals Healthcare Industry Insights

HealthTech Developments Paving the Way for $6.67 Billion MRD Testing Market by 2033

In the realm of medical diagnostics, technological advancements are often the catalysts that reshape the landscape. A prime example of this phenomenon is the rapid evolution of minimal residual disease (MRD) testing, a technique used to detect and quantify the small number of cancer cells that remain in a patient's body after treatment.

Topics: Pharmaceuticals Industry Insights

Liquid Biopsy-Based Multicancer Screening: An Exciting Frontier in Cancer Diagnosis

According to statistical data from the World Cancer Research Fund (WCRF) International, the incidence of cancer is increasing, especially, in countries with a low Human Development Index (HDI).

Topics: Pharmaceuticals Industry Insights

Active Pharmaceutical Ingredients (API) Market to Reach $258.6 Billion by 2027

Active pharmaceutical ingredients (APIs) are active ingredients or substances that produce a positive health effect on the patient to cure a specific condition or disease. Some medications, like combination therapy, contain several APIs that may work differently or address various symptoms. Hence, APIs are of great importance in both pharmaceutical and biopharmaceutical industries for drug and therapeutics manufacturing.

Topics: Pharmaceuticals Industry Insights

$8.8 Billion U.S. Medical Weight Loss Market Poised for Future Growth

The tide has turned to a greater focus on medical weight loss programs, many of which are now using the new obesity drugs. The big story of 2022 has been the soaring demand for new drugs such as Wegovy, Ozempic, and Saxenda, with more new drugs coming soon.

Topics: Pharmaceuticals Healthcare Industry Insights

Global Biopharmaceutical Market to Grow to Over $600 Billion by 2028

The biopharmaceutical sector is one of the most innovative industries in the world that has contributed significantly to developing novel drugs and vaccines for the treatment, prevention, and diagnosis of various diseases and disorders, such as cancer, neurological diseases, and metabolic disorders.

Topics: Pharmaceuticals Industry Insights

COVID-19 Pandemic Pushed Preventive Vaccine Market Value Toward $100 Billion

Preventive vaccines are administered to a person who is not affected by a targeted infection to induce the production of antibodies and strengthen the immune response to protect the person from future infections.

Topics: Pharmaceuticals Industry Insights

Expanding the Scope of Non-Invasive Molecular Oncology Diagnostics

The field of genomics has significantly positioned itself as a hotspot of academic scientific research and clinical medicine. Precision medicine and next-generation sequencing (NGS) are two examples of technological developments that have initiated substantial advancements in the field of oncology while also creating new opportunities for further growth.

Topics: Diagnostics Pharmaceuticals Industry Insights